COMPASSION-37: Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma (clinicaltrials.gov) - Sep 30, 2026 - P3 | N=900 | Recruiting | Sponsor: Akeso | Not yet recruiting ➔ Recruiting
Enrollment open • Esophageal Cancer • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Oncology • Solid Tumor • PD-L1
|